Brief: Intensity Therapeutics, Inc. Announces The Closing And Full Exercise Of The Over-Allotment Option From Its Upsized Initial Public Offering, Raising A Total Of $22.425 Million In Gross Proceeds
10/07/2023 13:47
Intensity Therapeutics Inc INTS.O :
* INTENSITY THERAPEUTICS, INC. ANNOUNCES THE CLOSING AND
FULL
EXERCISE OF THE OVER-ALLOTMENT OPTION FROM ITS UPSIZED INITIAL
PUBLIC OFFERING, RAISING A TOTAL OF $22.425 MILLION IN GROSS
PROCEEDS
Source text for Eikon: ID:nPn75W0t6a
Further company coverage: INTS.O
Recent news on Intensity Therapeutics
See all newsIntensity Therapeutics Q2 net loss widens as R&D costs rise
Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million
Intensity Therapeutics Q1 net loss narrows on lower R&D costs
Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million
Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing